Insufficient production or dysregulation of IL-10 disrupts the balance between pro-inflammatory and anti-inflammatory responses, contributing to the progression of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. Here, IL10 is linked to systemic lupus erythematosus.